518 related articles for article (PubMed ID: 22096243)
1. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S
Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
5. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
6. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.
Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Wang S; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
Orphanet J Rare Dis; 2014 Dec; 9():165. PubMed ID: 25475054
[TBL] [Abstract][Full Text] [Related]
8. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
9. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
13. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
15. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
17. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
18. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
